Posts Tagged ‘medical abortion’
CADTH recommends medical abortion reimbursement
Statement of Vicki Saporta, President and CEO of the National Abortion Federation Canada on the Canadian Agency for Drugs and Technologies in Health (CADTH) recommendation on Mifegymiso: We are pleased that CADTH has recommended that mifepristone and misoprostol be reimbursed for medical abortion care. CADTH’s recommendation will help make medical abortion care more widely accessible…
Read MoreNew FDA label for medical abortion pill, Mifeprex
Statement by Vicki Saporta, President and CEO of the National Abortion Federation (NAF), on the New FDA Label for Medical Abortion Pill, Mifeprex: We are delighted that the FDA has approved a label change, which brings the label for mifepristone in-line with scientific research and evidence-based practice. Since mifepristone was initially approved by the FDA…
Read MoreHealth Canada approves medical abortion medication
FOR IMMEDIATE RELEASE Wednesday, July 29, 2015 CONTACT: Alissa Manzoeillo 202.667.5881, ext 219; 202.595.4395 (after hours/cell) amanzoeillo@prochoice.org Statement of Vicki Saporta, President and CEO of the National Abortion Federation (NAF) and NAF Canada: The approval of mifepristone is great news for women in Canada. Mifepristone has been safely and effectively used by millions of…
Read MoreNAF’s President and CEO on AZ’s S.B. 1318: This is unacceptable and not how safe medical care of any kind is provided.
FOR IMMEDIATE RELEASE Tuesday, March 31, 2015 CONTACT: Alissa Manzoeillo 202.667.5881; 202.595.4395 (after hours/cell) amanzoeillo@prochoice.org Statement of Vicki Saporta, President and CEO of the National Abortion Federation, on Gov. Ducey’s signing Arizona’s S.B. 1318 into law: Last night, Arizona Governor Ducey signed into law extreme legislation that puts the health and safety of…
Read MoreNo Medical Reason for Requiring Ultrasound
Today, the Indianapolis Star, posted my letter to the editor on the state’s anti-choice legislation that would require women to get an ultrasound before a medication abortion. No matter what supporters of Senate Bill 37 say, this bill is a blatant example of anti-choice legislators attempting to practice medicine without a license. The bill would…
Read MoreStudy Finds Telemedicine a Safe, Effective Abortion Method
According to a new study published in the latest edition of Obstetrics and Gynecology, an abortion method that utilizes telemedicine technology to allow physicians to remotely provide medical abortion care to women is just as effective and acceptable to patients as a face-to-face office visit. A medical abortion is one that is brought about by…
Read MoreWednesday’s Words from Women
Twelve weeks into my pregnancy I began bleeding and having complications. My OB/GYN put me on bed rest for two months and I went to the doctor’s office once a week to be monitored. I ended up having to go to a specialist who told me that my baby had no fluid to survive. Due…
Read MoreWednesday’s Words from Women
Yesterday was the tenth anniversary of the FDA’s approval of mifepristone for early medical abortion. In honor of the anniversary, we are sharing the stories of two women who chose medical abortion to end an unwanted pregnancy. When I found out I was five weeks pregnant, I had been sick with persistent pneumonia for months…
Read MoreTenth Anniversary of FDA Approval of Mifepristone
Ten years ago today, the FDA approved the use of mifepristone as an alternative for terminating an early pregnancy. Mifepristone, also known as the “abortion pill,” Mifeprex, or RU-486, was first licensed in France in 1988, and has been used safely and effectively by millions of women worldwide. Since its FDA approval, usage in the…
Read MoreNew York Times Examines Medical Abortion Study
Today’s New York Times examines a recent study concerning medical abortion. Abortion providers and other experts had different reactions to the study, which suggests that infection rates can be reduced if the medication is taken by mouth instead of vaginally, and with antibiotics. Most providers agreed that it was reasonable to change to the oral…
Read More